(Q68207066)
Statements
Multiple myeloma: VMCP/VBAP alternating combination chemotherapy is not superior to melphalan and prednisone even in high-risk patients (English)
M Boccadoro
F Marmont
M Tribalto
G Avvisati
A Andriani
T Barbui
M Cantonetti
M Carotenuto
B Comotti
F Dammacco
1 March 1991